In certain solid tumors such as melanoma, lung, prostate cancer, and glioma, IGSF8 was shown to suppress tumor progression by modulating pathways like TGF-β and EGFR-MAPK, thereby inhibiting proliferation and metastasis (19–22). Here, TGFB1 is linked to neoplasm.